The main purpose of this legislation is to streamline the process for certain drugs, biological products, and medical devices to gain marketing approval in the United States if they are already authorized for sale in other countries. This is intended to improve access to potentially lifesaving treatments for patients in the U.S. by allowing products that meet specific criteria to be marketed more quickly. Key provisions of the legislation include the establishment of a system for reciprocal marketing approval.